Form 4 for CRVO CervoMed Inc.
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-17 · accession 0001437749-25-035655 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-19 | 2025-11-17+ | CRVO | Winton Matthew | Chief Commercial, Business | P - Purchase | $8.29 | +5,000 | 13.5K | +59% | +$41.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-18 | P | A | 1,500 | $7.95 | 15,000 | D | — | — | (F1) Shares purchased in open-market transactions. |
| 2 | Common | Common Stock | 2025-11-17 | P | A | 3,500 | $8.43 | 13,500 | D | — | — | (F1) Shares purchased in open-market transactions. |